Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients

BMC Family Practice

Volumn 14, Issue , 2013, Pages

  Mcgregor, Jessina C ^a   Elman, Miriam R ^a   Bearden, David T ^a   Smith, David H ^b  

^a OREGON STATE UNIVERSITY   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Escherichia coli; Urinary anti infectives; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN;

ADOLESCENT; ADULT; AGE; AGED; AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ARTICLE; CROSS-SECTIONAL STUDY; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; SEX DIFFERENCE; URINARY TRACT INFECTION; URINE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMBULATORY CARE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; AMPICILLIN; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NITROFURANTOIN; SEX FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874091333     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-14-25     Document Type: Article

References (19)

1. Ambulatory medical care utilization estimates for 2007. Schappert SM, Rechtsteiner EA, Vital Health Stat 2011 13 1 38
2. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of america and the European society for microbiology and infectious diseases. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE, Clin Infect Dis 2011 52 103 120
3. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Gupta K, Sahm DF, Mayfield D, Stamm WE, Clin Infect Dis 2001 33 89 94 (Pubitemid 32554508)
4. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF, Antimicrob Agents Chemother 2002 46 2540 2545 (Pubitemid 34793461)
5. Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Hooton TM, Johnson C, Winter C, Kuwamura L, Rogers ME, Roberts PL, Stamm WE, Antimicrob Agents Chemother 1991 35 1479 1483
6. European Association of Urology, Guidelines on Urological Infections Arnhem, The Netherlands: 2011 http://www.uroweb.org/gls/pdf/15-Urological- Infections.pdf
7. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. Ulleryd P, Zackrisson B, Aus G, Bergdahl S, Hugosson J, Sandberg T, BJU Int 1999 84 470 474 (Pubitemid 29419417)
8. Febrile urinary tract infection in men. Ulleryd P, Int J Antimicrob Agents 2003 22 Suppl 2 89 93
9. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Gupta K, Hooton TM, Stamm WE, Ann Intern Med 2001 135 41 50 (Pubitemid 32619282)
10. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA, Hoban DJ, Int J Antimicrob Agents 2006 27 468 475
11. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada-results of the CANWARD 2007-2009 study. Lagace-Wiens PR, Simner PJ, Forward KR, Tailor F, Adam HJ, Decorby M, Karlowsky J, Hoban DJ, Zhanel GG, Diagn Microbiol Infect Dis 2011 69 314 319
12. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline - Third Edition (M39-A3). Hindler JF, Barton M, Callihan DR, Erdman SM, Evangelista AT, Jenkins SG, Johnston J, Master R, McGowan J, John E, Nimmo G, Stelling J, Book Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline - Third Edition (M39-A3) Wayne, Pennsylvania: Clinical and Laboratory Standards Institute 2009 26
13. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). Linhares I, Raposo T, Rodrigues A, Almeida A, BMC Infect Dis 2013 13 19
14. Antibiotic resistance patterns in outpatient pediatric urinary tract infections. Edlin RS, Shapiro DJ, Hersh AL, Copp HL, J Urol 2013
15. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ, Int J Antimicrob Agents 2005 26 380 388 (Pubitemid 41483468)
16. Urinary Tract Infections. Sobel JD, Kaye D, Mandell, Douglas, and Bennett's principles and practice of infectious diseases New York: Elsevier/Churchill Livingstone, Mandell GL, Douglas RG, Bennett JE, Dolin R, 6 2005 875 905
17. UTIs in at-risk patients: Are they 'complicated'? McCue JD, Infect Med 1999 16 533 540 (Pubitemid 29420940)
18. Treatment of complicated and uncomplicated urinary tract infections. Anderson RU, Antibiotic therapy in urology Philadelphia: Lippincott-Raven Publishers, Mulholland SG, 1996 23 37
19. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection. Stuck AK, Tauber MG, Schabel M, Lehmann T, Suter H, Muhlemann K, Antimicrob Agents Chemother 2012 56 1359 1363